Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a belly ultrasound prevent a rare but deadly surgery complication?

NCT ID NCT06666049

Diagnosis Sponsor: Clinica Universidad de Navarra, Universidad de Navarra Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a bedside stomach ultrasound can help doctors assess the risk of food or liquid entering the lungs during surgery in patients taking GLP-1 drugs (like Ozempic). These drugs slow stomach emptying, which may increase risk even after standard fasting. Researchers will measure stomach volume in 39 adults before scheduled surgery to see if the ultrasound helps guide safer airway management.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Gastric ultrasound
What this could lead to
If successful, this could provide a simple, non-invasive way to identify patients at higher risk of aspiration during surgery, helping doctors make safer airway decisions.
What could go wrong
This is a small, early-stage study with only 39 participants, so results may not apply to all patients. The technique also depends on operator skill and may not always be accurate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 39 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2024

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The reference population will consist of patients undergoing scheduled surgery with a conventional preoperative fasting period (at least 6 hours).

Ages

18 to 90 years

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Adults patients ,ASA I-III, taking GLP-1 analog medications, undergoing scheduled surgery. Exclusion Criteria: 1. \- History of esophagogastric pathology or previous abdominal surgery. 2. \- Hiatal hernia/gastroesophageal reflux disease. 3. \- Autonomic nervous system disorders. 4. \- Neurological or neuromuscular diseases. 5. \- Use of medications/drugs that affect autonomic regulation and delay gastric emptying (opioids) or potentiate it (prokinetics). 6. \- Pregnancy. 7. \- Presence of arrhythmias.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Aspiration pneumonia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

aspiration pneumonia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Aspiration pneumonia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CAUSA Salamanca

    RECRUITING

    Salamanca, Spain

  • Clinica Universidad Navarra

    RECRUITING

    Madrid, Madrid, 28027, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.